Are Period Products Regulated by the FDA?

Yes — menstrual pads, tampons, and menstrual cups sold in the United States are regulated by the FDA as Class II medical devices. That sounds reassuring. But understanding what FDA regulation actually requires — and, critically, what it does not require — reveals a significant gap between regulatory clearance and what most people assume "FDA regulated" means.

The short version: FDA oversight addresses basic safety benchmarks and manufacturing quality. It does not require brands to disclose what their products are made of. That gap is not an accident, and it has real consequences for consumers trying to make informed choices.

What "Class II Medical Device" Actually Means

The FDA classifies medical devices into three risk tiers. Class I covers low-risk items like tongue depressors and bandages. Class III covers high-risk implantable devices like pacemakers. Class II sits in the middle and captures a broad range of products — including menstrual pads — that present moderate risk and require performance controls beyond general good manufacturing practice.

For menstrual products, Class II status means manufacturers must submit a 510(k) premarket notification before bringing a new product to market. This process requires demonstrating that the new device is "substantially equivalent" to a legally marketed predicate device — essentially proving that the new product is no more risky and performs similarly to something already on the market.

The governing regulation is 21 CFR Part 880, which specifically addresses obstetrical and gynecological devices. Menstrual pads fall under product code IYO. FDA clearance under this framework means the product met the agency's safety and effectiveness standard for its intended use — not that it is free of chemicals of concern.

What FDA Regulation Covers for Menstrual Pads

FDA oversight of Class II menstrual products addresses:

Manufacturing quality standards. Facilities must comply with the Quality System Regulation (21 CFR Part 820), which governs design controls, manufacturing processes, documentation, complaint handling, and corrective action procedures. This reduces the risk of contaminated or defective products reaching consumers.

Basic safety and labeling. Products must meet performance expectations for their stated use — absorbency claims need to be substantiated, labeling must be accurate, and the product must not present unreasonable risks during normal use.

Post-market surveillance. Manufacturers are required to report serious adverse events associated with their devices under the Medical Device Reporting regulation (21 CFR Part 803).

These are meaningful standards. They create a floor of quality and accountability that does not exist for cosmetics or food, which are regulated under different frameworks.

What FDA Regulation Does Not Cover

Here is where the gap becomes significant.

No Ingredient Disclosure Requirement

The FDA does not require menstrual pad manufacturers to disclose the specific materials or chemical components in their products. Unlike food (which has the Nutrition Facts label) or cosmetics (which require an ingredient list under INCI nomenclature), menstrual devices have no mandatory ingredient disclosure standard.

A pad can be legally sold in the United States with no information about what its top layer is made of, what bleaching process was used on its cotton, or what adhesive compounds are in its wings. Consumers have no regulatory mechanism to find out.

No Requirement to Disclose or Limit PFAS

Per- and polyfluoroalkyl substances (PFAS) — a class of persistent synthetic chemicals associated with endocrine disruption, immune system effects, and certain cancers — are not regulated or prohibited in menstrual products under current FDA rules. Several independent laboratory analyses, including a widely reported 2023 study published in Environment International, detected PFAS in commercially available period underwear and some pads. The FDA has no standard limiting or disclosing PFAS content in these products.

No Organic Certification or Pesticide Residue Standards

FDA clearance says nothing about whether the cotton in a pad is organic. A pad with conventional cotton — which may carry residual pesticides from the growing process — is treated identically under FDA frameworks to one with certified organic cotton. The organic certification infrastructure (ECOCERT, OCS, GOTS) is entirely separate from and independent of FDA oversight.

No Fragrance Composition Disclosure

This is perhaps the most consequential gap for everyday consumers. Under FDA regulations, fragrance formulas are protected as trade secrets. A manufacturer can list "fragrance" as a single ingredient on a label even if that fragrance blend contains dozens or hundreds of individual chemical compounds. The FDA does not require individual fragrance component disclosure for menstrual devices.

Synthetic fragrance compounds are among the most common contact allergens identified in dermatological patch testing. Several are also flagged as potential endocrine disruptors. For a product that contacts mucosal tissue for multiple hours per day, several days per month, over decades of a person's life — this disclosure gap is material.

The 2023 Menstrual Products Right to Know Act

In recent years, bipartisan legislative efforts have attempted to close the ingredient disclosure gap. The Menstrual Products Right to Know Act — versions of which have been introduced in Congress — would require manufacturers to disclose all intentionally added ingredients on product labels and online. As of 2025, this legislation has not yet been enacted into federal law, though several state-level efforts have produced partial disclosure requirements. New York's Menstrual Products Right to Know Act, passed in 2019, requires labeling of ingredients on tampons and pads sold in New York State — one of the first such laws in the US.

The trajectory is toward greater disclosure, but the current federal standard leaves consumers largely in the dark about product composition.

Why Third-Party Certifications Fill the Gap

Given what FDA regulation does and does not cover, independent third-party certifications are not redundant with FDA oversight — they address entirely different dimensions of product safety.

What It Addresses	FDA Regulation	Third-Party Certifications
Manufacturing quality	Yes (21 CFR Part 820)	Not the primary focus
Basic safety for intended use	Yes (510(k) clearance)	Indirectly
Ingredient disclosure	No	ECOCERT, OCS require ingredient transparency
Organic cotton verification	No	OCS, GOTS, ECOCERT Greenlife
Fragrance-free verification	No	ECOCERT, Dermatest
Pesticide residue limits	No	ECOCERT Greenlife, GOTS
PFAS absence	No	MADE SAFE, third-party lab testing
Skin tolerance (hypersensitive)	No	Dermatest Excellent
Bleaching process (H₂O₂ vs chlorine)	No	ECOCERT Greenlife, OCS

ECOCERT Greenlife is an internationally recognized organic certification body that verifies both input materials and manufacturing processes. ECOCERT's standard for personal care products and period care requires organic content verification, limits on permitted ingredients, and traceability through the supply chain.

Organic Content Standard (OCS) — maintained by Textile Exchange — independently verifies that a product contains a specific percentage of certified organic material and traces that material from the farm through the supply chain to the finished good.

Dermatest Excellent is a clinical skin tolerance certification issued by Dermatest GmbH, an independent German dermatological testing institute. The Excellent rating is the top tier of their assessment, validated on panels of hypersensitive skin volunteers — not just normal skin.

None of these certifications replace FDA regulatory compliance. They add layers of verified assurance that FDA oversight was never designed to provide.

What OCBON's Dual Compliance Means

OCBON pads are FDA registered — meaning they have been submitted through the 510(k) premarket notification process and comply with 21 CFR Part 880 quality and safety standards. That is the regulatory baseline.

On top of that baseline, OCBON carries:

• ECOCERT Greenlife certification — verified organic materials, no prohibited synthetic inputs
• OCS (Organic Content Standard) certification — supply chain traceability of the organic cotton content
• Dermatest Excellent — independently validated skin tolerance on hypersensitive skin panels
• H₂O₂ bleaching — no elemental chlorine, no dioxin byproducts
• Fragrance-free — no synthetic fragrance compounds, no masking agents

The combination matters because the regulatory floor and the certification standards address different dimensions. FDA registration confirms the product meets legal requirements for menstrual devices. The certifications confirm what is — and is not — in the product.

For consumers who want to verify claims rather than take marketing at face value, the certification databases are publicly searchable: ECOCERT's certificate database, Textile Exchange's OCS registry, and Dermatest's certification portal each allow independent verification.

For a deeper look at the specific chemicals of concern in conventional period products, see our guide on PFAS in period pads, and browse OCBON's organic cotton pad collection to see the full certification detail for each product.

---

Frequently Asked Questions

If the FDA regulates menstrual pads, why don't I know what's in them?

Because FDA regulation of menstrual devices does not include a mandatory ingredient disclosure requirement. The 510(k) premarket notification process focuses on demonstrating that a product is substantially equivalent to a predicate device in safety and performance — it does not require a public ingredient list. Fragrance formulas are also protected as trade secrets under FDA rules. This is why legislative efforts like the Menstrual Products Right to Know Act have focused on closing that specific disclosure gap.

Does FDA "registered" mean the same thing as FDA "approved"?

No. FDA registration means a manufacturing facility has registered with the FDA and the product has been submitted for review through the 510(k) premarket notification pathway — demonstrating substantial equivalence to an existing cleared device. FDA "approval" is a higher bar reserved primarily for Class III high-risk devices (like implantable cardiac devices) that require clinical trial evidence. Menstrual pads clear as Class II devices through the 510(k) pathway, which does not involve the same level of clinical evidence as a full approval process.

Are organic cotton pads regulated differently by the FDA than conventional pads?

No. FDA classification is based on the product's intended use and risk tier, not on whether its materials are organic. Both organic and conventional menstrual pads fall under the same Class II medical device framework (21 CFR Part 880). The organic certification is entirely independent of the FDA regulatory pathway — it is verified by separate third-party bodies like ECOCERT and OCS. A pad can be FDA cleared and not organic, or it can be FDA cleared and ECOCERT certified, as OCBON pads are.

What is the Menstrual Products Right to Know Act and has it passed?

The Menstrual Products Right to Know Act is federal legislation that would require manufacturers of tampons, pads, and other menstrual products to disclose all intentionally added ingredients on product labeling and websites. Versions of the bill have been introduced in Congress multiple times. As of 2025, it has not been enacted at the federal level. New York State passed its own version in 2019, making it one of the first states to require ingredient disclosure on menstrual products. Several other states have introduced similar legislation.